Paper33142138
Expression of NK cell receptor ligands in primary colorectal cancer tissue in relation to the phenotype of circulating NK- and NKT cells, and clinical outcome.
Krijgsman D and 8 others. Mol Immunol, 2020. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Expression of NK cell receptor ligands in primary colorectal cancer tissue in relation to the phenotype of circulating NK- and NKT cells, and clinical outcome. Papers, record 33142138. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33142138
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Expression of NK cell receptor ligands in primary colorectal cancer tissue in relation to the phenotype of circulating NK- and NKT cells, and clinical outcome.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colorectal Neoplasms | Major topic |
| Killer Cells, Natural | Major topic |
| Natural Killer T-Cells | Major topic |
| Receptors, Natural Killer Cell | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Disease-Free Survival | |
| Female | |
| Galectin 3 | |
| Histocompatibility Antigens Class I | |
| Humans | |
| Intracellular Signaling Peptides and Proteins | |
| Ligands | |
| Male | |
| Middle Aged | |
| Phenotype | |
| Proliferating Cell Nuclear Antigen |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42985438 | Viruses in the tumor immune microenvironment: implications for immunotherapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42985438 | PubMed |
| 42902385 | Epigenetic modulation of NKG2D ligands enhances NKG2D-CAR T cell efficacy in neuroblastoma. | J Transl Med | 2026 | https://conductscience.org/library/papers/42902385 | PubMed |
| 42807766 | Prognostic value of neuro-related genes in colorectal cancer and their potential implications for immunotherapy. | J Cancer | 2026 | https://conductscience.org/library/papers/42807766 | PubMed |
| 42792652 | The Galectin Family in Colorectal Cancer: Integrating Molecular Mechanisms with Diagnostic, Prognostic, and Therapeutic Perspectives. | Biomedicines | 2026 | https://conductscience.org/library/papers/42792652 | PubMed |
| 42373129 | Lenalidomide boosts CD1d-Vδ2 bispecific antibody-engaged Vγ9Vδ2-T cell effector functions via CD28, Notch signaling and IL-2 release. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42373129 | PubMed |
| 41516021 | The Need for a Systems Biology Approach in Cancer Explained. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41516021 | PubMed |
| 40583406 | NKT cells-a generalist in disease treatment and a new key to unlock immunotherapy. | Immunotherapy | 2025 | https://conductscience.org/library/papers/40583406 | PubMed |
| 40371166 | The role of glycan-lectin interactions in the tumor microenvironment: immunosuppression regulators of colorectal cancer. | Am J Cancer Res | 2025 | https://conductscience.org/library/papers/40371166 | PubMed |
| 39920524 | Integration of single-cell and bulk RNA-sequencing data to construct and validate a signature based on NK cell marker genes to predict immunotherapy response and prognosis in colorectal cancer. | Discov Oncol | 2025 | https://conductscience.org/library/papers/39920524 | PubMed |
| 38836911 | Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer. | J Gastroenterol | 2024 | https://conductscience.org/library/papers/38836911 | PubMed |
| 38486782 | CAR-NK cells in combination therapy against cancer: A potential paradigm. | Heliyon | 2024 | https://conductscience.org/library/papers/38486782 | PubMed |
| 38455977 | Circulation immune cell landscape in canonical pathogenesis of colorectal adenocarcinoma by CyTOF analysis. | iScience | 2024 | https://conductscience.org/library/papers/38455977 | PubMed |
| 38201234 | Can Galectin-3 Be a Novel Biomarker in Chronic Lymphocytic Leukemia? | Cells | 2023 | https://conductscience.org/library/papers/38201234 | PubMed |
| 37322531 | Immune profile of primary and recurrent epithelial ovarian cancer cases indicates immune suppression, a major cause of progression and relapse of ovarian cancer. | J Ovarian Res | 2023 | https://conductscience.org/library/papers/37322531 | PubMed |
| 36980678 | NKG2D Fine-Tunes the Local Inflammatory Response in Colorectal Cancer. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36980678 | PubMed |
| 36436018 | PD-1 expression, among other immune checkpoints, on tumor-infiltrating NK and NKT cells is associated with longer disease-free survival in treatment-naïve CRC patients. | Cancer Immunol Immunother | 2023 | https://conductscience.org/library/papers/36436018 | PubMed |
| 35887206 | NK Cells and Other Cytotoxic Innate Lymphocytes in Colorectal Cancer Progression and Metastasis. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35887206 | PubMed |
| 35741218 | Circulating Lymphocytes Reflect the Local Immune Response in Patients with Colorectal Carcinoma. | Diagnostics (Basel) | 2022 | https://conductscience.org/library/papers/35741218 | PubMed |
| 34925375 | The Role of the Tumor Microenvironment and Treatment Strategies in Colorectal Cancer. | Front Immunol | 2021 | https://conductscience.org/library/papers/34925375 | PubMed |
| 34858978 | Cross-Talk Between Tumor Cells Undergoing Epithelial to Mesenchymal Transition and Natural Killer Cells in Tumor Microenvironment in Colorectal Cancer. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34858978 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD1D | 912 | PubTator's text mining | https://conductscience.org/library/genes/912 | NCBI Gene |
| HLA-E | 3133 | PubTator's text mining | https://conductscience.org/library/genes/3133 | NCBI Gene |
| KLRD1 | 3824 | PubTator's text mining | https://conductscience.org/library/genes/3824 | NCBI Gene |
| LGALS3 | 3958 | PubTator's text mining | https://conductscience.org/library/genes/3958 | NCBI Gene |
| PCNA | 5111 | PubTator's text mining | https://conductscience.org/library/genes/5111 | NCBI Gene |
| RAET1G | 353091 | PubTator's text mining | https://conductscience.org/library/genes/353091 | NCBI Gene |
| ULBP1 | 80329 | PubTator's text mining | https://conductscience.org/library/genes/80329 | NCBI Gene |
| ULBP2 | 80328 | PubTator's text mining | https://conductscience.org/library/genes/80328 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33142138
GET https://conductscience.org/api/papers/v1/33142138/authors